As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by Planova™ virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, Planova™ filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers with products, services and expertise to achieve assurance that is beyond expectation. As part of our dedication to solving therapeutic product safety, efficiency and purity challenges, we also manufacture a comprehensive suite of downstream equipment. With technology platforms for virus filtration, chromatography, inline buffer formulation and oligonucleotide synthesis, our bioprocessing systems, columns and automation solutions advance GMP manufacturing of critical drug substances around the world. Our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.
View Top Employees from Asahi Kasei Bioprocess America, Inc.Website | http://www.ak-bio.com |
Revenue | $47 million |
Employees | 124 (119 on RocketReach) |
Address | 1855 Elmdale Ave., Glenview, Illinois 60026, US |
Phone | +91 22 6710 3962 |
Fax | (847) 556-9701 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Virus Filtration, Business Services, Science and Engineering, Chromatography Columns & Media, Downstream Bioprocessing, IBD™ In-Line Buffer Dilution Systems, Oligonucleotide Synthesis and Synthesizers |
Web Rank | 5 Million |
Keywords | Biopharmaceuticals, Good Manufacturing Practices, Drug Development And Manufacturing |
Competitors | Asahi Kasei Plastics North America, Inc., DAVCO Technology, LLC, LAKOS Filtration Solutions, PSI Global Limited, SABEU GmbH & Co. KG |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Asahi Kasei Bioprocess America, Inc. employee's phone or email?
The Asahi Kasei Bioprocess America, Inc. annual revenue was $47 million in 2024.
119 people are employed at Asahi Kasei Bioprocess America, Inc..
Asahi Kasei Bioprocess America, Inc. is based in Glenview, Illinois.
The NAICS codes for Asahi Kasei Bioprocess America, Inc. are [541, 54171, 541713, 54, 5417].
The SIC codes for Asahi Kasei Bioprocess America, Inc. are [873, 87].